Multiple resections for patients with glioblastoma: Prolonging survival

Journal of Neurosurgery

Volumn 118, Issue 4, 2013, Pages 812-820

  Chaichana, Kaisorn L ^a   Zadnik, Patricia ^a   Weingart, Jon D ^a   Olivi, Alessandro ^a   Gallia, Gary L ^a   Blakeley, Jaishri ^a   Lim, Michael ^a   Brem, Henry ^a   Quiñones Hinojosa, Alfredo ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Glioblastoma; Oncology; Prognosis; Resection; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; FRONTAL LOBE; FUNCTIONAL STATUS; GLIOBLASTOMA; HEADACHE; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; OCCIPITAL LOBE; OUTCOME ASSESSMENT; PARIETAL LOBE; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SEIZURE; SURVIVAL RATE; TEMPORAL LOBE;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; REGRESSION ANALYSIS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874606346     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.9.JNS1277     Document Type: Article

References (37)

1. Azizi A, Black P, Miyamoto C, Croul SE: Treatment of malignant astrocytomas with repetitive resections: a longitudinal study. Isr Med Assoc J 3:254-257, 2001
2. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, et al: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709-723, 1998
3. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008-1012, 1995
4. Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A: A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. Clinical article. J Neurosurg 112:997-1004, 2010
5. Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, et al: Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg 114: 587-594, 2011
6. Chaichana KL, Garzon-Muvdi T, Parker S, Weingart JD, Olivi A, Bennett R, et al: Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 18:239-245, 2011
7. Chaichana KL, Halthore AN, Parker SL, Olivi A, Weingart JD, Brem H, et al: Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg 114:604-612, 2011
8. Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A: Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 89:219-224, 2008
9. Chaichana KL, Zaidi H, Pendleton C, McGirt MJ, Grossman R, Weingart JD, et al: The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival. Neurol Res 33:759-764, 2011
10. Dandy WE: Removal of right cerebral hemisphere for certain tumors with hemiplegia. JAMA 90:823-825, 1928
11. DeAngelis LM: Brain tumors. N Engl J Med 344:114-123, 2001
12. Dutta D, Vanere P, Gupta T, Munshi A, Jalali R: Factors influencing activities of daily living using FIM-FAM scoring system before starting adjuvant treatment in patients with brain tumors: results from a prospective study. J Neurooncol 94:103-110, 2009
13. Gallia GL, Brem S, Brem H: Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Canc Netw 3:721-728, 2005
14. Genc M, Zorlu AF, Atahan IL: Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. Radiother Oncol 56:233-238, 2000
15. Harsh GR IV, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615-621, 1987
16. Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K: Temozolomide for high grade glioma. Cochrane Database Syst Rev (4):CD007415, 2008
17. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, et al: Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98:2678-2686, 2003
18. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005
19. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, et al: Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122:159-167, 2010
20. Keles GE, Anderson B, Berger MS: The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371-379, 1999
21. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-229, 2002
22. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
23. Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227-235, 2004
24. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007
25. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009
26. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463-470, 2009
27. McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, et al: Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Clinical article. J Neurosurg 110:583-588, 2009
28. Nieder C, Grosu AL, Molls M: A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 26:397-409, 2000
29. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al: An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812, 2008
30. Quiñones-Hinojosa A, Chaichana K: The human subventricular zone: a source of new cells and a potential source of brain tumors. Exp Neurol 205:313-324, 2007
31. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. Clinical article. J Neurosurg 115:3-8, 2011
32. Sathornsumetee S, Rich JN: New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 6:1087-1104, 2006
33. Stark AM, Nabavi A, Mehdorn HM, Blömer U: Glioblastoma multiforme - report of 267 cases treated at a single institution. Surg Neurol 63:162-169, 2005
34. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
35. Subach BR, Witham TF, Kondziolka D, Lunsford LD, Bozik M, Schiff D: Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery 45:17-23, 1999
36. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E: Gliadel wafer in initial surgery for malignant glioma: long-term followup of a multicenter controlled trial. Acta Neurochir (Wien) 148:269-275, 2006
37. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, et al: Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:257-2578, 1999